Optimisation of Intestinal Fibrosis and Survival in the Mouse S. Typhimurium Model for Anti-fibrotic Drug Discovery and Preclinical Applications.

Johnson, Laura A

Optimisation of Intestinal Fibrosis and Survival in the Mouse S. Typhimurium Model for Anti-fibrotic Drug Discovery and Preclinical Applications. [electronic resource] - Journal of Crohn's & colitis Jun 2017 - 724-736 p. digital

Publication Type: Journal Article

1876-4479

10.1093/ecco-jcc/jjw210 doi


Animals
Disease Models, Animal
Drug Discovery
Drug Evaluation, Preclinical
Female
Fibrosis--drug therapy
Intestines--pathology
Mice
Mice, Inbred C57BL
Mice, Inbred CBA
Mice, Inbred DBA
Nipecotic Acids--therapeutic use
Salmonella Infections, Animal--complications
Salmonella typhimurium
Survival Rate